Abiopharma

🔍 Van Heel Kenneth (Executive)

Company: SeaStar Medical Holding Corp (ICU)

Report Date: 2025-08-26

Detailed Transactions and Holdings:

• Acquired 25,000 shares of Common Stock, par value $0.0001 per share at $0.8899 per share (Direct)
  Date: 2025-08-26 | Code: P | equity_swap_involved: false | shares_owned_after: 39,400.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 10,000 shares of Common Stock, par value $0.0001 per share at $0.8565 per share (Direct)
  Date: 2025-08-27 | Code: P | equity_swap_involved: false | shares_owned_after: 49,400.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: The price reported in Row 1, Column 4 is a weighted average price of $0.8899. These shares were purchased in multiple transactions at prices ranging from $0.885 to $0.89 inclusive. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price.
• F2: The price reported in Row 2, Column 4 is a weighted average price of $0.8565. These shares were purchased in multiple transactions at prices ranging from $0.8531 to $0.8599 inclusive. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price.